“…A possible reason for this association is that obesity uncovers the effect of the PNPLA3 variant, increasing its effect size 73,77 . Additionally, quality of intrahepatic lipids, rather than quantity, may exert a major impact on the development of insulin resistance and glucose intolerance 6,7,78‐82 . In particular, in metabolically related FLD, but not in PNPLA3 ‐related FLD, the liver was found to be predominantly enriched with saturated triglycerides and with markers of de novo ceramides synthesis 6,7 .…”